Literature DB >> 23751822

The interplay between the X-DING-CD4, IFN-α and IL-8 gene activity in quiescent and mitogen- or HIV-1-exposed PBMCs from HIV-1 elite controllers, AIDS progressors and HIV-negative controls.

Rakhee Sachdeva1, Rasheda Y Shilpi, Malgorzata Simm.   

Abstract

X-DING-CD4 blocks HIV-1 long terminal repeat (LTR) and pathogen induced pro-inflammatory response. Increased activity of the X-DING-CD4 gene is associated with cellular resistance to virus; therefore, HIV-1 elite controllers (ECs) should have higher X-DING-CD4 and reduced pro-inflammatory mRNA activity than viremic or uninfected individuals. Also, depending on the cell stimulating factor, expression of X-DING-CD4 mRNA in ECs might be autonomous or contingent on IFN signaling. We compared expression of X-DING-CD4, IFN-α and IL-8 mRNAs in naive, phytohemagglutinin- or HIV-1 exposed PBMCs from ECs, HIV progressors and negative controls; tested correlation between X-DING-CD4 and IFN-α expression; sensitivity of the X-DING-CD4 gene to IFN-α regulation; and evaluated interactions between innate and pro-inflammatory genes. We found that expression of X-DING-CD4 and IFN-α was up-regulated in ECs and correlated in cells stimulated with mitogen, but not HIV-1. The X-DING-CD4 gene was more sensitive to HIV-1 than rIFN-α stimulation. ECs had significantly less IL-8 mRNA when PBMCs were exposed to exogenous HIV-1. Two-way ANOVA showed that control of HIV-1 and virus-induced pro-inflammatory response by ECs stemmed from interactions between expression of innate immunity and pro-inflammatory genes, the state of cell stimulation and the status of virus control. Consequently, interaction of multiple host innate immune responses rather than a single mechanism regulates restriction of HIV-1 in ECs.

Entities:  

Keywords:  DING protein; HIV-1 restriction; IFN-α; X-DING-CD4; elite HIV-1 controllers; innate immunity

Mesh:

Substances:

Year:  2013        PMID: 23751822      PMCID: PMC3883920          DOI: 10.1177/1753425913486162

Source DB:  PubMed          Journal:  Innate Immun        ISSN: 1753-4259            Impact factor:   2.680


  49 in total

1.  Replication-competent HIV strains infect HIV controllers despite undetectable viremia (ANRS EP36 study).

Authors:  Aurelia Lamine; Anne Caumont-Sarcos; Marie-Laure Chaix; Asier Saez-Cirion; Christine Rouzioux; Jean-François Delfraissy; Gianfranco Pancino; Olivier Lambotte
Journal:  AIDS       Date:  2007-05-11       Impact factor: 4.177

Review 2.  Understanding the "lucky few": the conundrum of HIV-exposed, seronegative individuals.

Authors:  Barbara L Shacklett
Journal:  Curr HIV/AIDS Rep       Date:  2006-02       Impact factor: 5.071

3.  Inhibition of HIV-1 or bacterial activation of macrophages by products of HIV-1-resistant human cells.

Authors:  Guanhua Li; Sagiv Aaron; Katarzyna Kazmierczak; Adam Lesner; Yuchang Li; Anna Ivanova; Galina Bentsman; Mary Jane Potash; Malgorzata Simm
Journal:  Immunol Cell Biol       Date:  2007-07-17       Impact factor: 5.126

4.  A soluble factor secreted by an HIV-1-resistant cell line blocks transcription through inactivating the DNA-binding capacity of the NF-kappa B p65/p50 dimer.

Authors:  Adam Lesner; Yuchang Li; Jadwiga Nitkiewicz; Guanhua Li; Alex Kartvelishvili; Magdalena Kartvelishvili; Malgorzata Simm
Journal:  J Immunol       Date:  2005-08-15       Impact factor: 5.422

5.  p27(SJ), a novel protein in St John's Wort, that suppresses expression of HIV-1 genome.

Authors:  N Darbinian-Sarkissian; A Darbinyan; J Otte; S Radhakrishnan; B E Sawaya; A Arzumanyan; G Chipitsyna; Y Popov; J Rappaport; S Amini; K Khalili
Journal:  Gene Ther       Date:  2006-02       Impact factor: 5.250

6.  Tandem purification of two HDL-associated partner proteins in human plasma, paraoxonase (PON1) and phosphate binding protein (HPBP) using hydroxyapatite chromatography.

Authors:  Frédérique Renault; Eric Chabrière; Jean-Pierre Andrieu; Bernard Dublet; Patrick Masson; Daniel Rochu
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2006-04-03       Impact factor: 3.205

7.  Isolation and characterization of replication-competent human immunodeficiency virus type 1 from a subset of elite suppressors.

Authors:  Joel N Blankson; Justin R Bailey; Seema Thayil; Hung-Chih Yang; Kara Lassen; Jun Lai; Shiv K Gandhi; Janet D Siliciano; Thomas M Williams; Robert F Siliciano
Journal:  J Virol       Date:  2006-12-06       Impact factor: 5.103

8.  APOBEC3G/CEM15 (hA3G) mRNA levels associate inversely with human immunodeficiency virus viremia.

Authors:  Xia Jin; Andy Brooks; Huiyuan Chen; Ryan Bennett; Richard Reichman; Harold Smith
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

Review 9.  Elite HIV controllers: myth or reality?

Authors:  Nitin K Saksena; Berta Rodes; Bin Wang; Vincent Soriano
Journal:  AIDS Rev       Date:  2007 Oct-Dec       Impact factor: 2.500

10.  Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity.

Authors:  Gang Peng; Ke Jian Lei; Wenwen Jin; Teresa Greenwell-Wild; Sharon M Wahl
Journal:  J Exp Med       Date:  2006-01-17       Impact factor: 14.307

View more
  3 in total

1.  Human X-DING-CD4 mediates resistance to HIV-1 infection through novel paracrine-like signaling.

Authors:  Rakhee Sachdeva; Yuchang Li; Rasheda Y Shilpi; Malgorzata Simm
Journal:  FEBS J       Date:  2015-01-27       Impact factor: 5.542

2.  DING proteins from phylogenetically different species share high degrees of sequence and structure homology and block transcription of HIV-1 LTR promoter.

Authors:  Rakhee Sachdeva; Nune Darbinian; Kamel Khalili; Shohreh Amini; Daniel Gonzalez; Ahmed Djeghader; Eric Chabriére; Andrew Suh; Ken Scott; Malgorzata Simm
Journal:  PLoS One       Date:  2013-08-06       Impact factor: 3.240

3.  Whole Exome Sequencing of HIV-1 long-term non-progressors identifies rare variants in genes encoding innate immune sensors and signaling molecules.

Authors:  Sara Konstantin Nissen; Mette Christiansen; Marie Helleberg; Kathrine Kjær; Sofie Eg Jørgensen; Jan Gerstoft; Terese L Katzenstein; Thomas Benfield; Gitte Kronborg; Carsten S Larsen; Alex Laursen; Gitte Pedersen; Martin R Jakobsen; Martin Tolstrup; Trine H Mogensen
Journal:  Sci Rep       Date:  2018-10-15       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.